New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October
In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group
Committee Kills Pay Raise Bill; Rauscher Probably Will Resign
Conferees Stalled On Money Bill, Running Out Of Time
NCAB Hung Up On removing $ 45 Million Limit For Core Grants
Obey Again – Now He’s Blasting NCI For Not Helping NIOSH
Abstracts Of Papers Presented By Breast Cancer Task Force
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









